Dexamethasone-induced changes in lung function are not prevented by concomitant treatment with retinoic acid.
Dexamethasone-induced changes in lung function are not prevented by concomitant treatment with retinoic acid.
复制标题
与视黄酸同时治疗并不能阻止地塞米松引起的肺功能变化。
DOI:
10.1152/ajplung.00423.2001
复制
发表时间:
2002
期刊:
影响因子:
--
通讯作者:
Bruce,MargaretC
中科院分区:
文献类型:
--
作者:
Srinivasan,Ganesh;Bruce,EugeneN;Houtz,PamelaK;Bruce,MargaretC
Alveolarization is impaired in rats treated with dexamethasone (Dex) on postnataldays 4–13, but concomitant treatment with all-transretinoic acid (RA) increases alveolar number. To determine whether morphological changes induced by Dex and/or RA predict changes in lung function at 1 mo, we assessed resting breathing parameters, dynamic compliance, ventilation required to maintain O2saturation at ≥90%, and pressure-volume curves of air-filled lungs. During resting breathing, mean tidal volume per gram was greater in Dex + RA-treated rats than in controls (P< 0.05). Dynamic compliance was also greater in Dex- and Dex + RA-treated rats than in controls or RA-treated rats (P< 0.02). In Dex- and Dex + RA-treated rats, we observed increased hysteresis ratios (P≤ 0.006), air trapping (P< 0.05), and lung volumes at 5 and 13.5 cmH2O pressure (P< 0.001) and decreased elastic recoil (P< 0.007). The effect of Dex on elastic recoil was greater in female than in male rats (P= 0.006). Despite impaired septation, O2saturation was not compromised in Dex- or Dex + RA-treated rats. Thus lung function changes induced by Dex treatment during alveolarization were not prevented by concomitant treatment with RA.